Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-16 5:08 pm Sale | 13G | DENALI THERAPEUTICS INC DNLI | Flagship Ventures Fund V L.P. | 2,730,263 2.2% | -5,250,000 (-65.79%) | View |
| 2021-02-16 12:24 pm Purchase | 13G | DENALI THERAPEUTICS INC DNLI | PRICE T ROWE ASSOCIATES INC | 6,464,826 5.3% | 6,464,826 (New Position) | View |
| 2021-02-12 4:19 pm Sale | 13G | DENALI THERAPEUTICS INC DNLI | BRATTON DOUGLAS K | 12,348,784 10.3% | -8,066,751 (-39.51%) | View |
| 2021-02-10 10:46 am Purchase | 13G | DENALI THERAPEUTICS INC DNLI | VANGUARD GROUP INC | 7,925,057 6.61% | 1,717,515 (+27.67%) | View |
| 2021-02-08 10:19 am Purchase | 13G | DENALI THERAPEUTICS INC DNLI | FMR LLC | 6,167,937 5.143% | 379,133 (+6.55%) | View |
| 2021-02-02 5:04 pm Purchase | 13G | DENALI THERAPEUTICS INC DNLI | ARCH Venture Fund VIII L.P. | 10,735,948 9% | 37,339 (+0.35%) | View |
| 2021-02-02 2:56 pm Purchase | 13G | DENALI THERAPEUTICS INC DNLI | BlackRock Inc. BLK | 6,376,078 5.3% | 1,348,764 (+26.83%) | View |
| 2021-01-12 09:24 am Purchase | 13G | DENALI THERAPEUTICS INC DNLI | BAILLIE GIFFORD & CO | 12,190,256 10.17% | 4,600,009 (+60.60%) | View |
| 2020-09-28 4:11 pm Purchase | 13G | DENALI THERAPEUTICS INC DNLI | BIOGEN INC. BIIB | 13,310,243 11.16% | 13,310,243 (New Position) | View |
| 2020-02-13 4:52 pm Sale | 13G | DENALI THERAPEUTICS INC DNLI | ARCH Venture Fund VIII L.P. | 10,698,609 11.1% | -370,140 (-3.34%) | View |
| 2020-02-13 4:18 pm Sale | 13G | DENALI THERAPEUTICS INC DNLI | Flagship Ventures Fund V L.P. | 7,980,263 8.3% | -938,486 (-10.52%) | View |
| 2020-02-12 11:13 am Sale | 13G | DENALI THERAPEUTICS INC DNLI | VANGUARD GROUP INC | 6,207,542 6.46% | -347,341 (-5.30%) | View |
| 2020-02-11 4:00 pm Sale | 13G | DENALI THERAPEUTICS INC DNLI | BRATTON DOUGLAS K | 20,415,535 21.3% | -158,763 (-0.77%) | View |
| 2020-02-10 2:19 pm Sale | 13G | DENALI THERAPEUTICS INC DNLI | BlackRock Inc. BLK | 5,027,314 4.8% | -220,264 (-4.20%) | View |
| 2020-02-07 11:18 am Sale | 13G | DENALI THERAPEUTICS INC DNLI | FMR LLC | 5,788,804 6.028% | -1,451,704 (-20.05%) | View |
| 2020-02-07 08:45 am Purchase | 13G | DENALI THERAPEUTICS INC DNLI | BlackRock Inc. BLK | 5,247,578 5.5% | 5,247,578 (New Position) | View |
| 2020-01-16 10:41 am Purchase | 13G | DENALI THERAPEUTICS INC DNLI | BAILLIE GIFFORD & CO | 7,590,247 7.9% | 1,362,523 (+21.88%) | View |